Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.

Ghadjar, Pirus

Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer. [electronic resource] - Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] Jul 2020 - 589-597 p. digital

Publication Type: Journal Article; Review

1439-099X

10.1007/s00066-020-01598-9 doi


Adenocarcinoma--drug therapy
Anastrozole--therapeutic use
Androgen Antagonists--adverse effects
Androgens
Anilides--adverse effects
Antineoplastic Agents, Hormonal--adverse effects
Dizziness--chemically induced
Dose Fractionation, Radiation
Drug Administration Schedule
Estrogen Receptor Modulators--administration & dosage
Flushing--chemically induced
Gynecomastia--chemically induced
Humans
Male
Mastodynia--chemically induced
Meta-Analysis as Topic
Neoplasms, Hormone-Dependent--drug therapy
Nitriles--adverse effects
Off-Label Use
Prostatic Neoplasms--drug therapy
Randomized Controlled Trials as Topic
Tamoxifen--administration & dosage
Tosyl Compounds--adverse effects